New Delhi, April 17 -- US pharmaceutical company Eli Lilly launched its once-a-week weight loss injection Mounjaro in India last month, reigniting interest in weight loss solutions, this time with a more clinical focus. Sensing an opportunity, new-age wellness startups have been launching alternative supplements that claim to naturally stimulate GLP-1, the hormone mimicked by Mounjaro and similar prescription drugs like Ozempic.

Health and wellness startups like The Good Bug, Wellbeing Nutrition and Veera Health are rolling out weight loss products that target appetite regulation, gut health and metabolic disorders. These are marketed as cheaper, easily accessible alternatives to weight loss injections.

With the conversation around weig...